Skip to main content
main-content

Rheumatology

Editor's pick

TNF inhibitors unlikely to raise cancer recurrence risk in RA patients

Needle

Treatment with tumour necrosis factor inhibitors is not associated with a significantly increased risk of recurrent cancer among patients with rheumatoid arthritis, researchers report.

Rheumatology

17-08-2018 | Rheumatology | News | Article

Intensive treatment in early arthritis patients provides long-term remission benefits

Short-term induction therapy with a tumor necrosis factor inhibitor plus methotrexate could alter disease development in some patients with early rheumatoid arthritis, providing long-term benefit, results of the DINORA trial suggest.

Source:

Arthritis Res Ther 2018; 20: 174

16-08-2018 | Rheumatology | News | Article

Predictors of remission in RA patients identified

Two studies have described factors associated with the achievement of sustained remission among patients with rheumatoid arthritis.

Source:

Rheumatology 2018; doi:10.1093/rheumatology/key202
Arthritis Res Ther 2018; 20: 165

15-08-2018 | Rheumatology | News | Article

Further evidence for the benefits of febuxostat in gout patients with renal impairment

Results of a phase III trial indicate that both the immediate and extended release formulations of febuxostat reduce serum uric acid levels in patients with gout, including those with impaired renal function.

Source:

Arthritis Rheumatol 2018; doi:10.1002/art.40685

13-08-2018 | Rheumatology | News

News in brief

Integrated dermatology–rheumatology clinic may improve PsA management

Collaboration between rheumatologists and dermatologists in a combined clinic may help improve outcomes for patients with psoriatic arthritis, study results suggest.

Twitter Icon Follow medwireNews

Click here
image credits